Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 76,914 | 33,733 | 47,976 | 156,819 | 84,903 |
| Marketable Securities | 315,395 | 387,079 | 394,442 | 379,567 | 274,204 |
| Other current assets | 2,370 | 1,263 | 135 | 1,573 | 904 |
| TOTAL | $402,770 | $431,382 | $451,273 | $543,731 | $364,806 |
| Non-Current Assets | |||||
| PPE Net | 12,748 | 11,759 | 11,881 | 12,184 | 12,118 |
| Investments And Advances | 90,182 | 102,478 | 125,187 | 74,692 | 45,305 |
| Other Non-Current Assets | 17,721 | 17,441 | 17,564 | 11,846 | 12,157 |
| TOTAL | $120,651 | $131,678 | $154,632 | $98,722 | $69,580 |
| Total Assets | $523,421 | $563,060 | $605,905 | $642,453 | $434,386 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,374 | 2,567 | 4,005 | 5,033 | 8,177 |
| Accrued Expenses | 21,738 | 20,777 | 22,971 | 19,219 | 14,668 |
| Other current liabilities | 272 | 576 | 228 | 375 | 114 |
| TOTAL | $87,500 | $88,339 | $92,542 | $94,493 | $108,685 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 59,460 | 60,852 | 61,739 | 66,234 | 82,263 |
| Other Non-Current Liabilities | 12,972 | 13,251 | 13,290 | 13,539 | 13,780 |
| TOTAL | $37,970 | $46,001 | $53,725 | $64,825 | $67,597 |
| Total Liabilities | $125,470 | $134,340 | $146,267 | $159,318 | $176,282 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,863 | 51,724 | 51,704 | 51,387 | 51,040 |
| Common Shares | 5 | 5 | 5 | 5 | 5 |
| Retained earnings | -305,923 | -265,666 | -228,982 | -195,082 | -166,500 |
| Other shareholders' equity | -3,983 | -3,216 | -660 | -146 | 0 |
| TOTAL | $397,951 | $428,720 | $459,638 | $483,135 | $258,104 |
| Total Liabilities And Equity | $523,421 | $563,060 | $605,905 | $642,453 | $434,386 |